Table 3.

Observed (Obs) and Expected (Exp) numbers and Standardized Incidence Ratio (SIR) of cancer among 455 Italian patients with CVID.

	Obs	Exp	SIR	95%CI
CANCER
All malignant neoplasms	133	55.1	2.4	1.7–3.5
Non-Hodgkin lymphoma	33	2.3	14.3	8.4–22.6
Gastric cancer	25	3.9	6.4	3.2–12.5
Colorectal cancer	10	8.2	1.2	0.0–1.9
Breast cancer	10	10	1	0.7–1.2
Thyroid cancer	5	1.7	2.9	0.0–6.4
Hodgkin Disease	5	0.4	12.5	3.4–22.4
Lung cancer	4	28	0.1	0.2–0.7
Liver cancer	4	2.1	1.9	0.3–5.6
Uterine cancer, body	4	1.2	3.3	0.1–6.5
Uterine cancer, cervical	3	1.2	2.5	0.1–4.8
Prostatic cancer	3	7.1	0.4	0.1–1.0
Pancreatic cancer	3	1.9	1.6	0.3–3.9